The controlled substances listed in this section are included in Schedule III.
SCHEDULE III
Stimulants.Any material, compound, mixture, or preparation which contains any quantity of the following substances or their salts, isomers, or salts of isomers, of the following substances:
Depressants.Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:
Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances which are specifically listed in other schedules;
Unless specifically excepted or unless listed in another schedule, any compound, mixture or preparation containing any of the following substances or any salt of the substances specifically included in this subsection (2) and one or more other active medicinal ingredients which are not listed in any other schedule:
Amobarbital;
Secobarbital;
Pentobarbital;
Any suppository dosage form containing any of the following substances or any salt of any of the substances specifically included in this subsection (3) approved by the Food and Drug Administration for marketing only as a suppository:
Amobarbital;
Secobarbital;
Pentobarbital;
Chlorhexadol;
Nalorphine.
Any material, compound, mixture or preparation which contains any quantity of ephedrine or pseudoephedrine.
Narcotic drugs.Any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:
Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;
Not more than one and eight-tenths (1.8) grams of codeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
Not more than one and eight-tenths (1.8) grams of dihydrocodeine, or any of its salts, per one hundred (100) milliliters or not more than ninety (90) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
Not more than three hundred (300) milligrams of ethylmorphine, or any of its salts, per one hundred (100) milliliters or not more than fifteen (15) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
Not more than five hundred (500) milligrams of opium per one hundred (100) milliliters or per one hundred (100) grams, or not more than twenty-five (25) milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts;
Not more than fifty (50) milligrams of morphine, or any of its salts, per one hundred (100) milliliters or per one hundred (100) grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts.
Anabolic steroids.Unless specifically exempted or listed in another schedule, any material, compound, mixture or preparation containing any quantity of any of the following anabolic steroids (any drug or hormonal substance chemically and pharmacologically related to testosterone other than estrogens, progestins, corticosteroids and dehydroepiandrosterone):
3beta,17-dihydroxy-5a-androstane;
3alpha,17beta-dihydroxy-5a-androstane;
5alpha-androstan-3,17-dione;
1-androstenediol (3beta,17beta-dihydroxy-5alpha-androst-1-ene);
1-androstenediol (3alpha,17beta-dihydroxy-5alpha-androst-1-ene);
4-androstenediol (3beta,17beta-dihydroxy-androst-4-ene);
5-androstenediol (3beta,17beta-dihydroxy-androst-5-ene);
1-androstenedione ([5alpha]-androst-1-en-3,17-dione);
4-androstenedione (androst-4-en-3,17-dione);
5-androstenedione (androst-5-en-3,17-dione);
Bolasterone (7alpha,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one);
Boldenone (17beta-hydroxyandrost-1,4,-diene-3-one);
Boldione (androsta-1,4-diene-3,17-dione);
Calusterone (7beta,17alpha-dimethyl-17beta-hydroxyandrost-4-en-3-one);
Clostebol (4-chloro-17beta-hydroxyandrost-4-en-3-one);
Any material, compound, mixture or preparation which contains any quantity of buprenorphine or its salts.
Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product.
Any material, compound, mixture or preparation which contains any quantity of a Schedule III controlled substance other than butalbital, and is listed as an exempt substance in 21 CFR, Section 1308.22, 1308.24, 1308.26, 1308.32 or 1308.34, shall be exempted from the provisions of the Uniform Controlled Substances Law.
Structure Mississippi Code
Chapter 29 - Poisons, Drugs and Other Controlled Substances
Article 3 - Uniform Controlled Substances Law
§ 41-29-107. Bureau of narcotics; composition; qualifications; dismissal
§ 41-29-109. Cooperation with bureau of narcotics
§ 41-29-110. Bureau of narcotics work program
§ 41-29-112. Special contract agents or investigators
§ 41-29-113. Schedule I of controlled substances
§ 41-29-115. Schedule II of controlled substances
§ 41-29-117. Schedule III of controlled substances
§ 41-29-119. Schedule IV of controlled substances
§ 41-29-121. Schedule V of controlled substances
§ 41-29-122. Exempt chemical preparations and mixtures
§ 41-29-123. Revision and republication of schedules
§ 41-29-127. Registration; factors considered
§ 41-29-129. Revocation and suspension of registration
§ 41-29-133. Records and inventories
§ 41-29-138. Applicability of avoirdupois system of weights
§ 41-29-139. Prohibited acts; penalties
§ 41-29-140. Fines and penalties; violation of Section 41-29-139
§ 41-29-141. Prohibited acts B; penalties
§ 41-29-143. Prohibited acts C; penalties
§ 41-29-145. Distribution to persons under age twenty-one
§ 41-29-147. Second and subsequent offenses
§ 41-29-149. Suspended sentences; eligibility for parole; resentencing
§ 41-29-151. Penalties to be additional; barring of prosecutions
§ 41-29-154. Disposition of seized controlled substances and paraphernalia
§ 41-29-157. Administrative inspection warrants and search warrants
§ 41-29-161. Bonds of bureau officers and employees
§ 41-29-163. Judicial review of final determinations, findings and conclusions
§ 41-29-165. Judicial review of convictions and orders
§ 41-29-167. Cooperative arrangements
§ 41-29-169. Drug abuse education programs
§ 41-29-171. Research programs on misuse and abuse of controlled substances
§ 41-29-173. Effect of Uniform Controlled Substances Law on pending proceedings
§ 41-29-175. Continuation of regulations
§ 41-29-176.1. Prosecution of cases involving seized property
§ 41-29-183. Procedure for disposition of seized property; exclusiveness of remedy
§ 41-29-189. Drug Evidence Disposition Fund created; purpose; sources of funds